The Rural Development Administration (RDA) of Korea has announced the expansion of commercialization for the Wonki 2 pepper leaf variety, which demonstrates excellent post-meal blood sugar suppression effects. Pepper leaves have traditionally been recognized for their ability to inhibit blood sugar spikes, attributed to their alpha-glucosidase inhibitor (AGI) activity. AGI is also used in pharmaceutical treatments for type 2 diabetes, a condition affecting 14.8% of Korean adults over 30. The RDA’s initiative addresses both public health concerns and the economic challenges facing the pepper industry.
The policy impacts Korean consumers seeking dietary solutions for blood sugar management, diabetes patients, and agricultural stakeholders. Wonki 2 pepper leaves exhibit AGI activity 2–5 times higher than standard pepper leaves, with animal studies showing significant improvements in 11 diabetes-related indicators. The commercialization process involves local agricultural technology centers, private seed companies, and food processors, with products ranging from teas and powders to chips, noodles, and tofu. The pepper industry, which has seen a 39.5% decrease in cultivation area over 15 years, stands to benefit from this new value-added model.
Since 2005, the RDA analyzed over 850 pepper genetic resources, developing Wonki 1 in 2008 and Wonki 2 in 2020, which has three times the AGI activity of its predecessor. Wonki 2 is now registered for plant variety protection (No. 10322) and patented for its use in metabolic disease prevention and treatment (No. 10-2705572). As of now, the variety and its technology have been transferred to eight companies, with more than ten processed food products commercialized. The RDA continues to support pilot cultivation, licensing, and technology transfer to expand market adoption.
Frequently asked questions include: What makes Wonki 2 pepper leaves unique? They offer significantly higher AGI activity, supporting blood sugar control and suitability for processed foods even under high-temperature and dry conditions. How does this benefit the pepper industry? By transforming pepper leaves from a by-product into a high-value ingredient, the initiative creates new revenue streams for farmers and processors. The RDA plans to accelerate functional vegetable breeding and expand research to meet consumer demands.
The Rural Development Administration’s approach to commercializing Wonki 2 pepper leaves is grounded in robust scientific evidence and addresses urgent public health and economic needs. By patenting and transferring technology, the RDA ensures broad industry adoption and consumer access. The initiative’s focus on functional foods aligns with global trends in preventive health and agricultural innovation. Transforming pepper leaves from a by-product into a valuable resource is likely to stimulate new growth in the pepper industry and offer meaningful dietary options for diabetes management.